Aperio Group LLC increased its position in shares of Colgate-Palmolive (NYSE:CL) by 6.1% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 547,977 shares of the company’s stock after purchasing an additional 31,588 shares during the period. Aperio Group LLC owned approximately 0.06% of Colgate-Palmolive worth $36,687,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Massachusetts Financial Services Co. MA raised its holdings in Colgate-Palmolive by 11.7% during the second quarter. Massachusetts Financial Services Co. MA now owns 32,560,326 shares of the company’s stock worth $2,110,235,000 after purchasing an additional 3,397,667 shares in the last quarter. Bank of New York Mellon Corp raised its holdings in Colgate-Palmolive by 8.6% during the second quarter. Bank of New York Mellon Corp now owns 20,135,385 shares of the company’s stock worth $1,304,974,000 after purchasing an additional 1,596,825 shares in the last quarter. OppenheimerFunds Inc. raised its holdings in Colgate-Palmolive by 6.4% during the second quarter. OppenheimerFunds Inc. now owns 6,785,987 shares of the company’s stock worth $439,801,000 after purchasing an additional 405,430 shares in the last quarter. Fiera Capital Corp raised its holdings in Colgate-Palmolive by 4.6% during the second quarter. Fiera Capital Corp now owns 5,012,573 shares of the company’s stock worth $324,865,000 after purchasing an additional 219,925 shares in the last quarter. Finally, Caisse DE Depot ET Placement DU Quebec raised its holdings in Colgate-Palmolive by 15.3% during the second quarter. Caisse DE Depot ET Placement DU Quebec now owns 4,093,312 shares of the company’s stock worth $265,288,000 after purchasing an additional 543,500 shares in the last quarter. 74.95% of the stock is owned by hedge funds and other institutional investors.
Several research analysts recently issued reports on the stock. UBS Group set a $71.00 price target on shares of Colgate-Palmolive and gave the stock a “buy” rating in a report on Wednesday. Wells Fargo & Co cut their price target on shares of Colgate-Palmolive from $64.00 to $62.00 and set a “market perform” rating for the company in a report on Wednesday. Zacks Investment Research cut shares of Colgate-Palmolive from a “hold” rating to a “sell” rating in a report on Friday, October 5th. Atlantic Securities assumed coverage on shares of Colgate-Palmolive in a report on Thursday, September 20th. They issued a “neutral” rating and a $71.00 target price for the company. Finally, Argus reaffirmed a “buy” rating and issued a $75.00 target price (up from $72.00) on shares of Colgate-Palmolive in a report on Tuesday, September 18th. Three research analysts have rated the stock with a sell rating, twelve have issued a hold rating and two have given a buy rating to the stock. The company presently has an average rating of “Hold” and an average price target of $70.79.
Shares of Colgate-Palmolive stock opened at $64.52 on Friday. Colgate-Palmolive has a 12-month low of $61.28 and a 12-month high of $77.91. The company has a debt-to-equity ratio of -34.49, a current ratio of 1.06 and a quick ratio of 0.74. The stock has a market capitalization of $55.14 billion, a price-to-earnings ratio of 22.48, a P/E/G ratio of 2.91 and a beta of 0.72.
Colgate-Palmolive (NYSE:CL) last issued its earnings results on Friday, July 27th. The company reported $0.77 earnings per share (EPS) for the quarter, meeting the Zacks’ consensus estimate of $0.77. Colgate-Palmolive had a net margin of 13.97% and a return on equity of 2,494.79%. The company had revenue of $3.89 billion during the quarter, compared to analysts’ expectations of $3.91 billion. During the same period last year, the company posted $0.72 earnings per share. The firm’s quarterly revenue was up 1.6% compared to the same quarter last year. As a group, sell-side analysts predict that Colgate-Palmolive will post 3 earnings per share for the current year.
The business also recently announced a quarterly dividend, which will be paid on Thursday, November 15th. Shareholders of record on Friday, October 19th will be issued a $0.42 dividend. The ex-dividend date of this dividend is Thursday, October 18th. This represents a $1.68 dividend on an annualized basis and a yield of 2.60%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 58.54%.
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. It operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The company offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; personal care products comprising bar and liquid hand soaps, shower gels, shampoos, conditioners, and deodorants and antiperspirants; and home care products, such as laundry and dishwashing detergents, fabric conditioners, household cleaners, and other related products.
Featured Article: What are the Different Types of Leveraged Buyouts?
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.